WHO Expert Panel approved wide use of AstraZeneca.

| | ,

0 0
Read Time:1 Minute, 1 Second
The benefits of the Covid-19 vaccine developed by AstraZeneca and Oxford University, more significant and the shot should be approved for use of senior citizen said by World Health Organization panel.
Meanwhile recommendations on the shot, the Strategic Advisory Group of Experts on Immunisation (SAGE) panel said “the vaccine should be given in two doses, within gap of around 8-12 weeks between first and second doses”
SAGE also said that even where questions have been raised about the vaccine’s efficacy against a South African variant of the coronavirus, “there is no reason not to recommend its use”.
South Africa this week paused the vaccination of AstraZeneca because they didn’t get the proper data of the efficiency of AstraZeneca vaccine.
The vaccination have been started almost all over the India, Covishield and Covaxin are the two vaccine which got the emergency approval few days back, Covaxin is India’s indigenous COVID-19 vaccine by Bharat Biotech which is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
The Union Health Ministry said on Thursday. India became the fastest country in the world to reach the 4 million COVID-19 vaccination mark.
Inputs from TOI
By-  BRATADEEP CHOUDHURY

About Post Author

The Business Daily

The Business Daily is North East India’s first Financial News Portal. This Pink Portal covers all big breaking news from the world of Business, Brands, Politics, Entertainments, Sports etc.
Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous

Amazon moves to Supreme Court seeking further deal dispute

Industry fair will focus on business in new normal

Next
Previous

Amazon moves to Supreme Court seeking further deal dispute

Industry fair will focus on business in new normal

Next

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Comment